WGU PHARMACOLOGY D441 NEWEST
VERSION PRACTICE SOLUTION SCRIPT
2026 FULL QUESTIONS WITH PRECISE
VERIFIED ANSWERS GRADED A+
⩥ absorption. Answer: medication absorbed in GI mucosa.
⩥ what effects absorption rate. Answer: fat, pH, concentration of
medication, length of contact, age, food, depth of breathing
⩥ distribution. Answer: medication transported via circulatory system to
point of action
⩥ metabolism. Answer: medication metabolized by liver
⩥ excretion. Answer: drug removed from body so they don't build up
⩥ US pharmacopia. Answer: created in 1820, where first listed drug
standards
⩥ controlled substance act of 1970. Answer: required hospitals to
register with DEA
,⩥ NCC MERP A. Answer: no error, capacity to cause error
⩥ NCC MERP B. Answer: error that didn't reach the patient
⩥ NCC MERP C. Answer: error that reached patient but unlikely to
cause harm
⩥ NCC MERP D. Answer: error that reached the patient, could have
necessitated monitoring and/or intervention to preclude harm
⩥ NCC MERP E. Answer: error that could have caused temporary harm
⩥ NCC MERP F. Answer: error that could have caused temporary harm
requiring initial, prolonged hospitalization
⩥ NCC MERP G. Answer: error that could have resulted in permanent
harm
⩥ NCC MERP H. Answer: error that could have necessitated
intervention to sustain life
⩥ NCC MERP I. Answer: error that could have resulted in death
, ⩥ FDA pregnancy risk A. Answer: lowest, studies have not shown a risk
to mother, fetus
⩥ FDA pregnancy risk B. Answer: slight, animal studies haven't shown
risk to fetus, human studies have not
⩥ FDA pregnancy risk C. Answer: moderate, animal studies have shown
risk to fetus, controlled studies not performed on women
⩥ FDA pregnancy risk D. Answer: risky, studies shows drugs may harm
fetus, may use if another safer therapy is unavailable
⩥ FDA pregnancy risk X. Answer: highest, studies shown significant
risk to mother, fetus
⩥ when is the fetus vulnerable to medication. Answer: first, third
trimester
⩥ schedule I drugs. Answer: high, not accepted medical use in US
⩥ schedule II drugs. Answer: high, may lead to severe dependence, no
refills unless a written perscription
VERSION PRACTICE SOLUTION SCRIPT
2026 FULL QUESTIONS WITH PRECISE
VERIFIED ANSWERS GRADED A+
⩥ absorption. Answer: medication absorbed in GI mucosa.
⩥ what effects absorption rate. Answer: fat, pH, concentration of
medication, length of contact, age, food, depth of breathing
⩥ distribution. Answer: medication transported via circulatory system to
point of action
⩥ metabolism. Answer: medication metabolized by liver
⩥ excretion. Answer: drug removed from body so they don't build up
⩥ US pharmacopia. Answer: created in 1820, where first listed drug
standards
⩥ controlled substance act of 1970. Answer: required hospitals to
register with DEA
,⩥ NCC MERP A. Answer: no error, capacity to cause error
⩥ NCC MERP B. Answer: error that didn't reach the patient
⩥ NCC MERP C. Answer: error that reached patient but unlikely to
cause harm
⩥ NCC MERP D. Answer: error that reached the patient, could have
necessitated monitoring and/or intervention to preclude harm
⩥ NCC MERP E. Answer: error that could have caused temporary harm
⩥ NCC MERP F. Answer: error that could have caused temporary harm
requiring initial, prolonged hospitalization
⩥ NCC MERP G. Answer: error that could have resulted in permanent
harm
⩥ NCC MERP H. Answer: error that could have necessitated
intervention to sustain life
⩥ NCC MERP I. Answer: error that could have resulted in death
, ⩥ FDA pregnancy risk A. Answer: lowest, studies have not shown a risk
to mother, fetus
⩥ FDA pregnancy risk B. Answer: slight, animal studies haven't shown
risk to fetus, human studies have not
⩥ FDA pregnancy risk C. Answer: moderate, animal studies have shown
risk to fetus, controlled studies not performed on women
⩥ FDA pregnancy risk D. Answer: risky, studies shows drugs may harm
fetus, may use if another safer therapy is unavailable
⩥ FDA pregnancy risk X. Answer: highest, studies shown significant
risk to mother, fetus
⩥ when is the fetus vulnerable to medication. Answer: first, third
trimester
⩥ schedule I drugs. Answer: high, not accepted medical use in US
⩥ schedule II drugs. Answer: high, may lead to severe dependence, no
refills unless a written perscription
